ArticleScientific reports2023

Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.